Journals / Anadolu Kardiyoloji Dergisi / 2002 / Cilt: 2 - Sayı: 3

The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy

Hipertrofik kardiyomiyopatili hastalarda QT dispersiyonu ile ani ölüm risk faktörleri arasındaki ilişki

Pages
226–230
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although QTd was significantly greater in patients with HCM than in normal controls, its relation to risk factors of sudden death could not be established.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Several risk factors are established for prediction of sudden cardiac death caused by ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM).
📊
Key Findings & Data:Methods: In the present study 48 patients with HCM and 30 normal subjects were studied.
💡
Conclusion & Impact:Conclusion: Although QTd was significantly greater in patients with HCM than in normal controls, its relation to risk factors of sudden death could not be established.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Several risk factors are established for prediction of sudden cardiac death caused by ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM). QT dispersion (QTd) is thought to reflect the heterogeneity of ventricular repolarization. The relation of QTd with ventricular arrhythmias and sudden cardiac death has been shown by several studies. The aim of this study is to examine whether there is a relationship between QTd and established risk factors of sudden cardiac death in patients with HCM. Methods: In the present study 48 patients with HCM and 30 normal subjects were studied. The patients with electrocardiographic changes that could affect QT interval measurements and those in whom QTd was calculated in less than 9 leads were excluded from the study. A family history of sudden death due to HCM, a history of ventricular fibrillation, nonsustained ventricular tachycardia on Holter monitoring and a history of recurrent syncope were accepted as risk factors for sudden cardiac death. Results: QTd was significantly greater in patients with HCM than in normal controls (55±22 ms vs 34±13 ms, p0.05). There was also no significant difference in QTd between patients with and without left ventricular outflow gradient >30 mmHg (57±23 ms vs 53±19 ms, p>0.05). Conclusion: Although QTd was significantly greater in patients with HCM than in normal controls, its relation to risk factors of sudden death could not be established.

Özet

Amaç: Hipertrofik kardiyomiyopatili (HKM) hastalarda görülebilen ventrikül aritmilerine bağlı ani ölümlerin önceden tahmininde kullanılan bazı risk faktörleri belirlenmiştir. QT dispersiyonu (QTd) ventrikül repolarizasyonundaki heterojeniteyi gösterir ve ventriküler aritmilerle ve ani kalp ölümü ile ilişkili olduğu ortaya konmuştur. Bu çalışmanın amacı HKM'li hastalarda belirlenen ani ölüm risk faktörleri ile QTd arasında ilişkinin araştırılmasıdır. Yöntem: Çalışmada HKM tanısı ile takip ve tedavi altında olan 48 hasta ve kontrol grubu olarak 30 sağlıklı birey incelendi. QT ölçümünü etkileyebilecek EKG değişiklikleri olan ya da teknik olarak EKG'de 9 derivasyondan fazla ölçüm yapılamayan hastalar çalışma dışı bırakıldı. Ailede HKM'ye bağlı ani ölümün olması, ventrikül fibrilasyon öyküsü, Holter kayıtlarında sürekli olmayan ventrikül taşikardi ataklarının görülmesi ve tekrarlayıcı senkop atakları ani ölüm açısından risk faktörleri olarak kabul edildi. Bulgular: Normal hastalarla karşılaştırıldığında HKM'li hastaların QTd'nun belirgin artmış olduğu gözlendi. (34±13 ms ile 55±22 ms, p0.05). Sol ventrikül çıkış gradiyenti 30 mmHg üstünde olan (n=12) ile olmayan hastalar karşılaştırıdığında yine iki grup arasında QTd açısından anlamlı fark saptanmamıştır (57±23 ms ile 53±19 ms, p>0.05). Sonuç: HKM'li hastalarda QTd, normal popülasyona göre artmış bulunmakla beraber ani kardiyak ölüm için belirlenmiş risk faktörleri ile ilişkisi gösterilememiştir.

🔖

Cite This Article

RİTSUSHI, K., MATSUMOTO, K., HIROSHI, M., GÖKTEKİN, Ö. (2022). The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy. Anadolu Kardiyoloji Dergisi, Cilt: 2 - Sayı: 3, 226–230. https://ajindex.com/articles/437563

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Maron BJ, Savage DD, Wolfson JF, Epstein SE. Prognostic significanse of 24-hour ambulatory monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981; 48: 252-7
  2. Maron BJ, Shen W-K, Link MS, et al. Efficacy of implantable cardioverter –defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365-73
  3. Mc Kenna WJ, Deanfield J, Faruqui A, England D, Oakley CM, Goodwin JR. Prognosis in hypertrophic cardiomyopathy: role of age, and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-8
  4. Fananapazir L, Chang AC, Ebstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, haemodynamic, and electrophysiological findings. Circulation 1992; 86: 730-40
  5. McKenna WJ, England D, Doi JL, Deanfield J, Oakley CM, Goodwin JR. Arrhythmia in hypertrophic cardiomyopathy. Influence on prognosis. Br Heart J 1981; 46: 168-72
  6. Sadoul N, Prasad K, Elliott P, Bannerjee S, Frenneaux M, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997; 96: 2987-91
  7. Moreno FL, Villanueva MT, Karagounis LA, Anderson JL. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. Circulation 1994; 90: 94-100
  8. Dritsas A, Sbarouni E, Gilligan D, Nihoyannopoulos P, Oakley CM. QT interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992; 15: 739-42
  9. Miorelli M, Buja G, Melacini P, et al. QT interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol 1994; 45: 121-7
  10. Scwartz PJ, Wolf MD. QT interval prolongation as a predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57: 1074-7
  11. Perkiomaki JS, Koistinen J, Yli-Mayry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26: 174-9
  12. Report of the 1995 World Health Organisation /International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996: 93; 841-2
  13. Malik M, Camm AJ. Mystery of QTc interval dispersion. Am J Cardiol 1997; 79: 785-7
  14. Zaidi M, Robert A, Fesler R, Derwael C